Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Price-to-earnings ratio
3Y CAGR
+109.2%/yr
Annual compound
Percentile
P89
Within normal range
vs 3Y Ago
9.2x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 51.87 | +258.6% |
| 2024 | -32.71 | -137.5% |
| 2023 | 87.25 | +1439.3% |
| 2022 | 5.67 | +210.9% |
| 2021 | -5.11 | +24.5% |
| 2020 | -6.77 | -83.4% |
| 2019 | -3.69 | +54.1% |
| 2018 | -8.04 | +17.5% |
| 2017 | -9.74 | +63.0% |
| 2016 | -26.37 | - |